Geometry Dash APK Hill Climb Racing APK
74.5 F
New York
Tuesday, September 21, 2021

Novavax, Inc. (NASDAQ:NVAX) Rebounds Ahead of Phase 1/2 Trial Data

Must read

Medmen Enterprises Inc (OTCMKTS:MMNFF) Pulls Back From Highs as Buzz Cools Off

Among the sectors which have bounced back in 2021, the cannabis sector is one of considerable interest since it had been in...

VirtualArmour International Inc (OTCMKTS:VTLR) Jumps Another 250% This Week

Not every move in the stock market can always be explained and hence, investors are often rightly confused when a stock records...

Ozop Energy Solutions Inc (OZSC) is Riding a Green Wave of Momentum

Investors who are looking for fresh opportunities in rising stocks may have a lot to choose from at this point but it...

Drone Delivery Canada Corp (OTCMKTS:TAKOF) is Soaring after Roadmap Update

The drone industry has grown at a remarkable rate over the past five years or so and hence, it is no surprise...

In recent times, Novavax, Inc. (NASDAQ:NVAX) has emerged as one of the better-performing stocks from the biotech sector. Earlier this year, the company announced significantly positive news with regards to NanoFlu, its flu vaccine product.

Investors are also awaiting data from the company’s Phase 1/2 trial, which is expected to be presented during the CDC ACIP meeting on October 30th

Coronavirus Play

However, it is as a ‘coronavirus play’ that the company has managed to really emerge as a winner as far as the stock price goes. Hence, it could be a good idea for investors to ponder if the Novavax stock can be a long term play or not.

In this regard, it is important to note that the company’s experimental COVID 19 vaccine NVX-CoV2373 is far from a sure thing yet. Many of the biggest pharmaceutical companies have paused their late-stage testing due to complications. Hence, it remains to be seen if Novavax’s vaccine manages to get emergency use authorization from the FDA.

On the other hand, NanoFlu is yet to get approval from the regulators. Hence, there is a significant degree of uncertainty with regard to Novavax’s two projects that have contributed to the rally this year.

Additionally, even if the two products are approved by the FDA, there is the possibility of similar vaccines from other companies proving to be more effective.

However, there is a certain degree of optimism about both products among experts. Additionally, if that happens, then the company could see revenue jump over the next five years. If it all pans out in that fashion, the Novavax could eventually be worth significantly more in half a decade and is worth keeping on the radar.

Latest article

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...

Net Savings Link Inc (OTCMKTS:NSAV) Goes Parabolic Ahead of Important Event

As far as cryptocurrency and blockchain companies are concerned, there are many options nowadays for investors to explore.

Dark Pulse Inc (OTCMKTS:DPLS) Stock Moves in a Range After The Big Rally

The laser sensing system company Dark Pulse Inc (OTCMKTS:DPLS) has emerged as one of the major gainers over the course of the...

Halberd Corporation (OTCMKTS:HALB) Stock Doubles After ‘Proof of Concept’ News

Investors are always on the lookout for stocks which managed to record handsome gains over a short of period of time and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service